secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2026-06-08T21:00:43+00:00
Accession:  0001493152-26-027751
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mira Pharmaceuticals appoints fractional CFO after CFO Weichselbaum departs
---------------------------------------------------------------------------

- Alan Weichselbaum resigned as CFO effective June 6, 2026, with no disagreement with the company.
- Andriy Mushak, CPA with over 20 years SEC experience, appointed fractional CFO effective June 6, 2026.
- Mushak will serve via consulting agreement with LMAM Consulting Group; company to pay $6,000 per month.
- Mushak's expertise includes SEC reporting, audit readiness, internal controls, and capital-markets support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315226027751/0001493152-26-027751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315226027751/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer